Skip to main navigation Skip to search Skip to main content

Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-κB and AP-1

  • Luis A. Ortiz
  • , Hunter C. Champion
  • , Joseph A. Lasky
  • , Federica Gambelli
  • , Evelyn Gozal
  • , Gary W. Hoyle
  • , Mary B. Beasley
  • , Albert L. Hyman
  • , Mitchell Friedman
  • , Philip J. Kadowitz

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Abstract

The present study was undertaken to investigate the effects of treatment with the angiotensin-converting enzyme (ACE) inhibitor enalapril in a mouse model of pulmonary hypertension induced by bleomycin. Bleomycin-induced lung injury in mice is mediated by enhanced tumor necrosis factor-α (TNF) expression in the lung, which determines the murine strain sensitivity to bleomycin, and murine strains are sensitive (C57BL/6) or resistant (BALB/c). Bleomycin induced significant pulmonary hypertension in C57BL/6, but not in BALB/c, mice; average pulmonary arterial pressure (PAP) was 26.4 ± 2.5 mmHg (P < 0.05) vs. 15.2 ± 3 mmHg, respectively. Bleomycin treatment induced activation of nuclear factor (NF)-κB and activator protein (AP)-1 and enhanced collagen and TNF mRNA expression in the lung of C57BL/6 but not in BALB/c mice. Double TNF receptor-deficient mice (in a C57BL/6 background) that do not activate NF-κB or AP-1 in response to bleomycin did not develop bleomycin-induced pulmonary hypertension (PAP 14 ± 3 mmHg). Treatment of C57BL/6 mice with enalapril significantly (P < 0.05) inhibited the development of pulmonary hypertension after bleomycin exposure. Enalapril treatment inhibited NF-κB and AP-1 activation, the enhanced TNF and collagen mRNA expression, and the deposition of collagen in bleomycin-exposed C57BL/6 mice. These results suggest that ACE inhibitor treatment decreases lung injury and the development of pulmonary hypertension in bleomycin-treated mice.

Original languageEnglish
Pages (from-to)L1209-L1221
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume282
Issue number6 26-6
DOIs
StatePublished - 2002
Externally publishedYes

Keywords

  • Activator protein-1
  • Angiotensin II
  • Nuclear factor-κB
  • Pulmonary hypertension
  • Tumor necrosis factor

Fingerprint

Dive into the research topics of 'Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-κB and AP-1'. Together they form a unique fingerprint.

Cite this